title: Elixir Medical's bioresorbable drug eluting stent (BDES) programme: an overview.
authors.affiliation: Elixir Medical Corporation, 870 Hermosa Drive, Sunnyvale, CA 94085, USA.
authors.forename: John
authors.initials: J
authors.lastname: Yan
authors.forename: Vinayak D
authors.initials: VD
authors.lastname: Bhat
mesh_terms: D020341:Absorbable Implants; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation*; D000818:Animals; D002317:Cardiovascular Agents / Q000008:administration & dosage; D003324:Coronary Artery Disease / Q000628:therapy*; D054855:Drug-Eluting Stents; D006801:Humans; D016730:Program Development; D011474:Prosthesis Design
chemical_list: D002317:Cardiovascular Agents